Sage Journals: Discover world-class research

Abstract

The use of the non-human primate in long-term studies of contraceptive steroids has been questioned because of time, expense and apparent lack of results predictive for humans. Controversies have arisen primarily over the occurrence of mammary nodules in studies of different contraceptive steroids and the occurrence of uterine tumors in 2 high-dose group monkeys in the Depo-Provera study. The long-term studies have been criticized because of the experimental design and the small number of monkeys per dose group. Individual studies by themselves did not reveal lesions other than those expected from an exaggerated pharmacologic response of target tissues; however, a pattern may emerge from reviewing and combining results of different studies that indicate the results of these studies are in agreement with the clinical findings in man. Effects of contraceptive steroids on the mammary gland and genital organs will be discussed. Data from 17 contraceptive steroid studies involving 264 untreated control and 733 treated non-human primates were available.

Keywords

Rhesus monkey progestins estrogens long-term studies tumors epithelial plaque deciduomal reaction uterus mammary gland

References

1. Berliner VR (1974). US Food and Drug Administration requirements for toxicity testing of contraceptive products. In: Pharmacological Models in Contraceptive Development, MH Briggs and ED Diczfalusy (eds). Acta Endocrinol. Suppl. 185: 240–253.

2. Casey HW , Giles RC , and Kwapien RP (1979). Mammary neoplasia in animals: Pathological aspects and the effects of contraceptive steroids. Recent Results in Cancer Research 66: 129–160.

3. DiGiacomo RF and McCann TO (1970). Gynecologic pathology in the Macaca mulatta. Am. J. Obstet. Gynecol. 108: 538–542.

4. El Etreby MF (1980). Comparative aspects of the influence of contraceptive steroids on tumorigenesis in the reproductive organs of experimental animals and man. In: Animal Models in Human Reproduction, M Serio and L Martini (eds). Raven Press, New York, pp. 443–453.

5. Fitzgerald J , de la Iglesia F , and Goldenthal EI (1982). Ten-year oral toxicity study with Norlestrin in rhesus monkeys. J. Tox. Env. Health 10: 879–896.

6. Geil RG and Lamar JK (1977). FDA studies of estrogen, progestogens and estrogen/progestogen combinations in the dog and monkey. J. Tox. Env. Health 3: 179–193.

7. Goldenthal EI (1969). Contraceptives, estrogens and progestogens: A new FDA policy on animal studies. FDA Papers 3 15: .

8. Hisaw FL , Hisaw FL Jr , and Dawson AB (1967). Effects of relaxin on the endothelium of endometrial blood vessels in monkeys (Macaca mulatta). Endocrinology 81: 375–385.

9. Kelly WA , Marston JH , and Eckstein P (1969). Effect of intrauterine device on endometrial morphology and the deciduomal reaction of the rhesus monkey. J. Repro. Fertil. 19: 331–340.

10.

10. Kiaer HW , Kiaer WW , Linell F , and Jacobsen S (1979). Extreme duct papillomatosis of the juvenile breast. Acta Path. Microbiol. Scand. Sect. A 87: 353–359.

11.

11. King NW Jr (1987). Personal communication. New England Regional Primate Research Center, Southborough, MA.

12.

12. Kirschstein RL , Rabson AS , and Rusten GW (1972). Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: A preliminary report. J. Natl. Cancer Inst. 48: 551–556.

13.

13. Lowenstine LJ (1986). Neoplasms and proliferative disorders in nonhuman primates. In: Primates–The Road to Self-Sustaining Populations, K Benirschke (ed). Springer-Verlag, New York, pp. 781–814.

14.

14. Nelson LW and Shott LD (1973). Mammary nodular hyperplasia in intact rhesus monkeys. Vet. Pathol. 10: 130–134.

15.

15. Rossman I (1940). The deciduomal reaction in the rhesus monkey (Macaca mulatta). 1. The epithelial proliferation. Amer. J. Anat. 66: 277–365.

16.

16. Squire RA , Goodman DG , Valerio MG et al (1978). Tumors. In: Pathology of Laboratory Animals, K Benirschke , FM Garner , and TC Jones (eds). Springer-Verlag, New York, pp. 1052–1283.

17.

17. Tatum, Population Council Study.

18.

18. Tavassoli FA , Casey HW , and Norris HJ (1988). The morphologic effects of synthetic reproductive steroids on the mammary gland of rhesus monkeys. Am. J. Path. 131: 213–234.

19.

19. Wadsworth PF , Heywood R , Allen DG , et al (1979). Treatment of rhesus monkeys (Macaca mulatta) with intrauterine devices loaded with levonorgestrel. Contraception 20: 177–184.

20.

20. Warner MR (1979). Mammary pathology. In: Aging in Nonhuman Primates, DM Bowden (ed). Van Norstrand Reinhold, New York, pp. 210–228.

21.

21. Wislocki GB (1933). The reproductive systems. In: The Anatomy of the Rhesus Monkey, CG Hartman and WL Strauss (eds). Williams & Wilkins, Baltimore, p. 239.

22.

22. Wislocki GB and Streeter GL (1938). On the placentation of the macaque (Macaca mulatta) from the time of implantation until the formation of the definitive placenta. Contrib. to Embryol. 27: 1–66, No. 160, Carnegie Inst. Wash. Publ.

Comparative Aspects of Contraceptive Steroids: Effects Observed in the Monkey

Abstract

Keywords

References